INAB insider transaction filings
IN8BIO, INC. — 39 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-05-29. Screen INAB transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-05-29 | 4 | FAIRBAIRN EMILY — Director | Gift (G): 724,637 @ $0 | EDGAR |
| 2026-05-12 | 4 | Graff Jeremy R. — Director | Grant/award (A): 22,000 (derivative) @ $0 | EDGAR |
| 2026-05-12 | 4 | Rochlin Kate — President and COO | Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2026-05-12 | 4 | McCall Patrick — CHIEF FINANCIAL OFFICER | Grant/award (A): 56,250 (derivative) @ $0 | EDGAR |
| 2026-05-12 | 4 | Greenwood Luba — Director | Grant/award (A): 22,000 (derivative) @ $0 | EDGAR |
| 2026-05-12 | 4 | Epperly Corinne — Director | Grant/award (A): 22,000 (derivative) @ $0 | EDGAR |
| 2026-05-12 | 4 | Ho William Tai-Wei — CEO, Director | Grant/award (A): 154,500 (derivative) @ $0 | EDGAR |
| 2026-05-12 | 4 | Lamb Lawrence — EVP and CSO | Grant/award (A): 54,000 (derivative) @ $0 | EDGAR |
| 2026-05-12 | 4 | FAIRBAIRN EMILY — Director | Grant/award (A): 22,000 (derivative) @ $0 | EDGAR |
| 2026-05-12 | 4 | Brandt Peter C. — Director | Grant/award (A): 22,000 (derivative) @ $0 | EDGAR |
| 2026-02-06 | 4 | Rochlin Kate — President and COO | Grant/award (A): 80,000 (derivative) @ $0 | EDGAR |
| 2026-02-06 | 4 | McCall Patrick — CHIEF FINANCIAL OFFICER | Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2026-02-06 | 4 | Ho William Tai-Wei — CEO, Director, 10% owner | Grant/award (A): 206,000 (derivative) @ $0 | EDGAR |
| 2026-02-06 | 4 | Lamb Lawrence — EVP and CSO | Grant/award (A): 72,000 (derivative) @ $0 | EDGAR |
| 2025-12-23 | 4 | Rochlin Kate — Chief Operating Officer | Grant/award (A): 7,247 @ $1.38 | EDGAR |
| 2025-12-23 | 4 | McCall Patrick — CHIEF FINANCIAL OFFICER | Grant/award (A): 7,247 @ $1.38 | EDGAR |
| 2025-12-23 | 4 | Ho William Tai-Wei — PRESIDENT AND CEO, Director, 10% owner | Grant/award (A): 36,232 @ $1.38 | EDGAR |
| 2025-12-23 | 4 | FAIRBAIRN EMILY — Director | Grant/award (A): 724,637 @ $1.38 | EDGAR |
| 2025-12-23 | 4 | Roemer Alan S. — Director | Grant/award (A): 36,232 @ $1.38 | EDGAR |
| 2025-12-23 | 4 | Brandt Peter C. — Director | Grant/award (A): 72,464 @ $1.38 | EDGAR |
| 2025-05-12 | 4 | Greenwood Luba — Director | Grant/award (A): 63,150 (derivative) @ $0 | EDGAR |
| 2025-05-12 | 4 | Graff Jeremy R. — Director | Grant/award (A): 63,150 (derivative) @ $0 | EDGAR |
| 2025-05-12 | 4 | Epperly Corinne — Director | Grant/award (A): 63,150 (derivative) @ $0 | EDGAR |
| 2025-05-12 | 4 | FAIRBAIRN EMILY — Director | Grant/award (A): 63,150 (derivative) @ $0 | EDGAR |
| 2025-05-12 | 4 | Roemer Alan S. — Director | Grant/award (A): 63,150 (derivative) @ $0 | EDGAR |
| 2025-05-12 | 4 | Brandt Peter C. — Director | Grant/award (A): 63,150 (derivative) @ $0 | EDGAR |
| 2025-05-07 | 4 | Lamb Lawrence — EVP and CSO | Disposition to issuer (D): 1,639 (derivative) · Grant/award (A): 1,639 (derivative) | EDGAR |
| 2025-05-07 | 4 | Graff Jeremy R. — Director | Disposition to issuer (D): 2,049 (derivative) · Grant/award (A): 2,049 (derivative) | EDGAR |
| 2025-05-07 | 4 | Epperly Corinne — Director | Disposition to issuer (D): 81,967 (derivative) · Grant/award (A): 81,967 (derivative) | EDGAR |
| 2025-05-07 | 4 | Ho William Tai-Wei — PRESIDENT AND CEO, Director, 10% owner | Disposition to issuer (D): 81,967 (derivative) · Grant/award (A): 81,967 (derivative) · Disposition to issuer (D): 81,967 (derivative) · Grant/award (A): 81,967 (derivative) @ $0.18 | EDGAR |
| 2025-05-07 | 4 | Rochlin Kate — Chief Operating Officer | Option exercise (M): 12,295 @ $0.18 · Disposition to issuer (D): 12,295 (derivative) · Grant/award (A): 12,295 (derivative) · Option exercise (M): 12,295 (derivative) @ $0 · Disposition to issuer (D): 12,295 (derivative) · Grant/award (A): 12,295 (derivative) | EDGAR |
| 2025-05-07 | 4 | McCall Patrick — CHIEF FINANCIAL OFFICER | Option exercise (M): 15,000 @ $0.18 · Disposition to issuer (D): 15,000 (derivative) · Grant/award (A): 15,000 (derivative) · Option exercise (M): 15,000 (derivative) @ $0 · Disposition to issuer (D): 20,492 (derivative) · Grant/award (A): 20,492 (derivative) | EDGAR |
| 2025-05-07 | 4 | Kreis Leslie W. — 10% owner BIOS Fund III, LP — 10% owner BIOS Fund III QP, LP — 10% owner BIOS Fund III NT, LP — 10% owner Bios Equity Partners II, LP — 10% owner BIOS Equity Partners III, LP — 10% owner BP Directors, LP — 10% owner Bios Equity Partners, LP — 10% owner Cavu Management, LP — 10% owner Cavu Advisors, LLC — 10% owner | Purchase (P): 1,148,482 (derivative) · Other (J): 574,241 (derivative) · Other (J): 574,241 (derivative) | EDGAR |
| 2025-05-07 | 4 | Roemer Alan S. — Director | Option exercise (M): 102,459 @ $0.18 · Option exercise (M): 11,000 @ $0.18 · Disposition to issuer (D): 102,459 (derivative) · Grant/award (A): 102,459 (derivative) · Option exercise (M): 102,459 (derivative) @ $0 · Disposition to issuer (D): 102,459 (derivative) · +3 more | EDGAR |
| 2025-05-07 | 4 | Brandt Peter C. — Director | Option exercise (M): 81,967 @ $0.18 · Option exercise (M): 81,967 @ $0.18 · Disposition to issuer (D): 81,967 (derivative) · Grant/award (A): 81,967 (derivative) · Option exercise (M): 81,967 (derivative) @ $0 · Disposition to issuer (D): 81,967 (derivative) · +2 more | EDGAR |
| 2025-02-07 | 4 | McCall Patrick — CHIEF FINANCIAL OFFICER | Grant/award (A): 343,000 (derivative) @ $0 | EDGAR |
| 2025-02-07 | 4 | Lamb Lawrence — EVP and CSO | Grant/award (A): 306,750 (derivative) @ $0 | EDGAR |
| 2025-02-07 | 4 | Rochlin Kate — Chief Operating Officer | Grant/award (A): 338,950 (derivative) @ $0 | EDGAR |
| 2025-02-07 | 4 | Ho William Tai-Wei — PRESIDENT AND CEO, Director, 10% owner | Grant/award (A): 912,450 (derivative) @ $0 | EDGAR |
Recent 8-K events — IN8BIO, INC.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-06 | 8-K | 2.02 — Results of Operations and Financial Condition | EDGAR |
| 2026-06-01 | 8-K | 1.01 — Entry into a Material Definitive Agreement 1.02 — Termination of a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-07 | 8-K | 2.02 — Results of Operations and Financial Condition 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-03-12 | 8-K | 2.02 — Results of Operations and Financial Condition | EDGAR |
| 2026-02-27 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-02-09 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2025-12-19 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-24 | 8-K | 8.01 — Other Events | EDGAR |
| 2025-11-06 | 8-K | 2.02 — Results of Operations and Financial Condition | EDGAR |
| 2025-10-27 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=INAB returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →